Guo, S., Chen, D., Huang, X., Cai, J., Wery, J., & Li, Q. (2016). Cetuximab response in CRC patient-derived xenografts seems predicted by an expression based RAS pathway signature. Oncotarget.

Guo, Sheng, Dawei Chen, Xuesong Huang, Jie Cai, Jean-Pierre Wery, and Qi-Xiang Li. "Cetuximab Response in CRC Patient-derived Xenografts Seems Predicted By an Expression Based RAS Pathway Signature." Oncotarget 2016.

Guo, Sheng, et al. "Cetuximab Response in CRC Patient-derived Xenografts Seems Predicted By an Expression Based RAS Pathway Signature." Oncotarget 2016.